These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9790962)

  • 21. Biological and structural comparison of recombinant phospholipase D toxins from Loxosceles intermedia (brown spider) venom.
    Ribeiro RO; Chaim OM; da Silveira RB; Gremski LH; Sade YB; Paludo KS; Senff-Ribeiro A; de Moura J; Chávez-Olórtegui C; Gremski W; Nader HB; Veiga SS
    Toxicon; 2007 Dec; 50(8):1162-74. PubMed ID: 17900646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression.
    Tambourgi DV; Paixão-Cavalcante D; Gonçalves de Andrade RM; Fernandes-Pedrosa Mde F; Magnoli FC; Paul Morgan B; van den Berg CW
    J Invest Dermatol; 2005 Apr; 124(4):725-31. PubMed ID: 15816830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey for potentially necrotizing spider venoms, with special emphasis on Cheiracanthium mildei.
    Foradori MJ; Smith SC; Smith E; Wells RE
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 May; 141(1):32-9. PubMed ID: 15979415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Loxtox protein family in Loxosceles intermedia (Mello-Leitão) venom.
    Kalapothakis E; Chatzaki M; Gonçalves-Dornelas H; de Castro CS; Silvestre FG; Laborne FV; de Moura JF; Veiga SS; Chávez-Olórtegui C; Granier C; Barbaro KC
    Toxicon; 2007 Dec; 50(7):938-46. PubMed ID: 17825864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a 27-residue peptide.
    Dias-Lopes C; Guimarães G; Felicori L; Fernandes P; Emery L; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Toxicon; 2010; 55(2-3):481-7. PubMed ID: 19818803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: molecular cloning, expression, function and structural analysis.
    de Santi Ferrara GI; Fernandes-Pedrosa Mde F; Junqueira-de-Azevedo Ide L; Gonçalves-de-Andrade RM; Portaro FC; Manzoni-de-Almeida D; Murakami MT; Arni RK; van den Berg CW; Ho PL; Tambourgi DV
    Toxicon; 2009 Jun; 53(7-8):743-53. PubMed ID: 19249326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
    Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
    Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venom of the Brazilian spider Sicarius ornatus (Araneae, Sicariidae) contains active sphingomyelinase D: potential for toxicity after envenomation.
    Lopes PH; Bertani R; Gonçalves-de-Andrade RM; Nagahama RH; van den Berg CW; Tambourgi DV
    PLoS Negl Trop Dis; 2013; 7(8):e2394. PubMed ID: 23991242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brown spider phospholipase-D containing a conservative mutation (D233E) in the catalytic site: identification and functional characterization.
    Vuitika L; Gremski LH; Belisário-Ferrari MR; Chaves-Moreira D; Ferrer VP; Senff-Ribeiro A; Chaim OM; Veiga SS
    J Cell Biochem; 2013 Nov; 114(11):2479-92. PubMed ID: 23733617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two new phospholipase D isoforms of Loxosceles laeta: cloning, heterologous expression, functional characterization, and potential biotechnological application.
    Catalán A; Cortes W; Sagua H; González J; Araya JE
    J Biochem Mol Toxicol; 2011; 25(6):393-403. PubMed ID: 21692149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
    de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
    Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiotoxic effects of Loxosceles intermedia spider venom and the recombinant venom toxin rLiD1.
    Dias-Lopes C; Felicori L; Guimarães G; Gomes ER; Roman-Campos D; Duarte H; Damasceno D; Martins M; Kalapothakis E; Almeida AP; Granier C; Cruz JS; Guatimosim S; Chávez-Olórtegui C
    Toxicon; 2010 Dec; 56(8):1426-35. PubMed ID: 20826175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis.
    Tambourgi DV; Morgan BP; de Andrade RM; Magnoli FC; van Den Berg CW
    Blood; 2000 Jan; 95(2):683-91. PubMed ID: 10627480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification, cloning, expression and functional characterization of an astacin-like metalloprotease toxin from Loxosceles intermedia (brown spider) venom.
    da Silveira RB; Wille AC; Chaim OM; Appel MH; Silva DT; Franco CR; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
    Biochem J; 2007 Sep; 406(2):355-63. PubMed ID: 17535156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
    Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
    Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between calcium and the metabolism of plasma membrane phospholipids in hemolysis induced by brown spider venom phospholipase-D toxin.
    Chaves-Moreira D; Souza FN; Fogaça RT; Mangili OC; Gremski W; Senff-Ribeiro A; Chaim OM; Veiga SS
    J Cell Biochem; 2011 Sep; 112(9):2529-40. PubMed ID: 21590705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loxosceles gaucho spider venom and its sphingomyelinase fraction trigger the main functions of human and rabbit platelets.
    Tavares FL; Peichoto ME; Rangel Dde M; Barbaro KC; Cirillo MC; Santoro ML; Sano-Martins IS
    Hum Exp Toxicol; 2011 Oct; 30(10):1567-74. PubMed ID: 21247992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemolysis induced by Loxosceles laeta venom. In vitro experience].
    Bravo M; Puratic O; Behn C; Fardella C; Contreras A
    Rev Med Chil; 1993 Jan; 121(1):16-20. PubMed ID: 8235159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of membrane phospholipids, the cytosolic calcium influx and cell proliferation following treatment of B16-F10 cells with recombinant phospholipase-D from Loxosceles intermedia (brown spider) venom.
    Wille AC; Chaves-Moreira D; Trevisan-Silva D; Magnoni MG; Boia-Ferreira M; Gremski LH; Gremski W; Chaim OM; Senff-Ribeiro A; Veiga SS
    Toxicon; 2013 Jun; 67():17-30. PubMed ID: 23462381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and molecular cloning of insecticidal toxins from the venom of the brown spider Loxosceles intermedia.
    de Castro CS; Silvestre FG; Araújo SC; Gabriel de MY; Mangili OC; Cruz I; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2004 Sep; 44(3):273-80. PubMed ID: 15302533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.